Domestic Sunitinib is about $1300 – $5500 per box. Sunitinib is an antitumor drug. It is used for gastrointestinal mesenchymal stromal tumors and inoperable advanced renal cell carcinoma that have…
Date of approval.Date of revision.Sunitinib Malate Capsules Instructions for UsePlease read the instructions carefully and use under the guidance of a physicianWarning: HepatotoxicityHepatotoxic reactions have been observed in patients in…
Sunitinib is a multi-target receptor tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor 1-2 (VEGFR1-2), platelet-derived growth factor receptor (PDGFR-α, PDGFR-β), stem cell growth factor receptor (c-KIT), and…
Sunitinib is a multi-target receptor tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor 1-2 (VEGFR1-2), platelet-derived growth factor receptor (PDGFR-α, PDGFR-β), stem cell growth factor receptor (c-KIT), and…
1. Which patients can use sunitinib? Which patients should not use it? . Sunitinib (sotan) is recommended for first-line treatment of advanced clear cell type renal cell carcinoma. However, it…
Spelling: Shu Ni Ti Ni English name: Sunitinib Drug class: protein kinase inhibitor [otw_shortcode_tabslayout tabs=”8″ tab_1_title=”Overview” tab_1_content=”Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that reduces tumor cell proliferation and…